‘Rediscovered’ Lymphoma Drug Helps Double Survival: Study

<p>SUNDAY, Jun 3 (HealthDay News) A drug initial grown in East
Germany in a 1960s has re-emerged as a manly new arms against
certain forms of non-Hodgkin lymphomas, researchers report.
The drug, bendamustine, some-more than doubled illness progression-free
survival when given along with another therapy, rituximab (Rituxan),
compared to a drug cocktail thats prolonged been used to quarrel indolent
non-Hodgkin lymphomas.
The bendamustine/rituximab multiple also left patients with fewer
side effects than a comparison treatment, a hearing found.
One expert, Dr. Joshua Brody, an partner highbrow of
hematology/oncology during Mount Sinai School of Medicine in New York City,
called a commentary quite exciting.
Simultaneously augmenting efficiency and dwindling toxicity is a rare
win-win in oncology, and this has already stirred an huge change in
the approach we caring for these patients, he said.
The commentary were presented Sunday during a annual assembly of the
American Society of C...